Crizotinib in Patients With MET-Amplified NSCLC. Camidge DR, Otterson GA, Clark JW, Ignatius Ou SH, et al. J Thorac Oncol 2021;16:1017-1029.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Camidge DR, Otterson GA, Clark JW, Ignatius Ou SH, et al. Crizotinib in Patients With MET-Amplified NSCLC. J Thorac Oncol 2021;16:1017-1029.
PMID: 33676017